Bone and Mineral Metabolism

ea0110p4 | Bone and Mineral Metabolism

Consistent reduction in rate of fracture with setrusumab therapy in patients with osteogenesis imperfecta: month 14 data from phase 2 of the orbit study

ea0110p5 | Bone and Mineral Metabolism

Pathophysiology of osteoporosis (PATHOS Study): role of hidden cortisol excess (HidHyCo) and its predictors in bone fragility, preliminary results

ea0110p6 | Bone and Mineral Metabolism

Parathyroid surgery in children with sporadic and familial hyperparathyroidism

ea0110p200 | Bone and Mineral Metabolism

Bone microarchitectural degradation in hypertensive patients: a population study

ea0110p201 | Bone and Mineral Metabolism

The effect of low-dose cyclic 17-ß-estradiol administration on bone turnover in healthy postmenopausal women: a randomized controlled trial

ea0110p202 | Bone and Mineral Metabolism

Assessing PTH dynamics following total thyroidectomy: an important tool for predicting hypoparathyroidism

ea0110p203 | Bone and Mineral Metabolism

Quality of life assessed by HPES and HPQ28 questionnaires in patients with post-surgical hypoparathyroidism: correlation with biochemical and clinical features

ea0110p204 | Bone and Mineral Metabolism

Switch from rhpth1-84 to transcon PTH with individual dose adjustment in adult hypoparathyroidism – results for 40 patients one month after treatment transition

ea0110p205 | Bone and Mineral Metabolism

Bone health in cleidocranial dysplasia: a large single-centre UK case series and literature review

ea0110p206 | Bone and Mineral Metabolism

Serum phosphate as a marker of disease severity in primary hyperparathyroidism

ea0110p207 | Bone and Mineral Metabolism

Classification of bone turnover and calcium metabolism markers based on the molecular subtypes of osteogenesis imperfecta

ea0110p208 | Bone and Mineral Metabolism

Autosomal dominant hypocalcemia type 1 or type 2: baseline characteristics of pediatric participants in the CLARIFY disease monitoring study

ea0110p209 | Bone and Mineral Metabolism

Caloric restriction exerts duration-dependent effects on marrow adiposity, bone structure, & metabolic health

ea0110p210 | Bone and Mineral Metabolism

A novel method for the detection of hypercalciuria in individuals with chronic hypoparathyroidism

ea0110p211 | Bone and Mineral Metabolism

Cardiovascular disease in patients with post-surgical hypoparathyroidism

ea0110p212 | Bone and Mineral Metabolism

Deeplasia: a novel tool for the assessment of bone age in skeletal dysplasia

ea0110p213 | Bone and Mineral Metabolism

Switch from rhPTH1-84 to transcon PTH in patients with hypoparathyroidism normalizes phosphate, magnesium metabolism, and bone turnover

ea0110p214 | Bone and Mineral Metabolism

Risk of non-completion of sequential osteoporosis therapy after teriparatide treatment - real-life data from Hungary

ea0110p215 | Bone and Mineral Metabolism

Wide clinical spectrum of GCM2-related primary hyperparathyroidism

ea0110p216 | Bone and Mineral Metabolism

Risk of atypical femoral fractures among osteoporotic patients on denosumab treatment in real-life setting: a population-based study

ea0110p217 | Bone and Mineral Metabolism

Histopathological and clinical differences in primary hyperparathyroidism: a retrospective analysis of parathyroid adenomas with severe and mild hypercalcemia

ea0110p218 | Bone and Mineral Metabolism

Quantitative evaluation of hypophosphatemic rickets due to ENPP1 deficiency

ea0110p219 | Bone and Mineral Metabolism

Preliminary results from a prospective cohort study on real-world data of chronic hypoparathyroidism treated with trans-con PTH

ea0110p220 | Bone and Mineral Metabolism

Relation of body composition with 3D-DXA parameters and trabecular bone score in women with anorexia nervosa

ea0110p221 | Bone and Mineral Metabolism

Treatment of hypercalciuria in patients with chronic hypoparathyroidism

ea0110p222 | Bone and Mineral Metabolism

Effect of thiazide diuretics on bone turnover in osteoporotic postmenopausal patients with idiopathic hypercalciuria

ea0110p223 | Bone and Mineral Metabolism

FGF23 in chronic hypoparathyroidism: clinical implications of phosphate regulation

ea0110p224 | Bone and Mineral Metabolism

Clinical and phenotypic features of osteogenesis imperfecta caused by fkbp10 mutations: a study of skeletal deformities and cervical abnormalities

ea0110p225 | Bone and Mineral Metabolism

The role of FGF23 in phosphorus and calcium metabolism: lessons from diseases affecting serum phosphate levels

ea0110p227 | Bone and Mineral Metabolism

Gain-of-function CASR variants identified as a major genetic contributor of non-surgical hypoparathyroidism: findings from over 300 participants in a sponsored genetic testing program

ea0110p228 | Bone and Mineral Metabolism

Skeletal characterization of patients with PLS3-associated early onset osteoporosis in comparison to patients with osteogenesis imperfecta type i

ea0110p229 | Bone and Mineral Metabolism

X-linked hypophosphatemic rickets and FGF23 levels: the importance of a correct reference range

ea0110p230 | Bone and Mineral Metabolism

Getting bone health right from the start: new tools for bone mineral density evaluation and determinants of BMD from pregnancy to 12 months of life

ea0110p231 | Bone and Mineral Metabolism

Genotype-phenotype insights and longitudinal outcomes in WNT1-related osteogenesis imperfecta type XV: a 14-year study of 44 chinese patients

ea0110p232 | Bone and Mineral Metabolism

Increased MMP13-bip interaction and activated ER stress contribute to SEMD in patient-ipsc-derived chondrogenic with MMP13 variant

ea0110p233 | Bone and Mineral Metabolism

Non-interventional post-authorisation safety study of burosumab in the treatment of children and adolescents with X-linked hypophosphataemia: second interim analysis

ea0110p234 | Bone and Mineral Metabolism

CALIBRATE-PEDS: a phase 2/3, multicenter, single-arm study evaluating the pharmacokinetics, efficacy, and safety of encaleret in pediatric participants with autosomal dominant hypocalcemia type 1

ea0110p235 | Bone and Mineral Metabolism

Triptorelin effects on linear growth and bone mineral density in transgender adolescents: a longitudinal study

ea0110p236 | Bone and Mineral Metabolism

Vitamin D supplementation during pregnancy does not improve maternal bone mineral density at 4 years post-partum

ea0110p237 | Bone and Mineral Metabolism

Characterization of bone density, strength, and mineral metabolism in 20 adults with monoallelic ENPP1 pathogenic variants

ea0110p238 | Bone and Mineral Metabolism

Estimating the risk of chronic kidney disease progression in chronic hypoparathyroidism: a retrospective matched cohort study, using real world data from England

ea0110p239 | Bone and Mineral Metabolism

Evaluation of ALP and PLP as a screening tool for ALPL mutations in hypophosphatasia: a study in chinese pediatric patients

ea0110p240 | Bone and Mineral Metabolism

Renal safety of zoledronic acid infusion in osteoporosis patients: a retrospective analysis

ea0110p241 | Bone and Mineral Metabolism

Real-world bone health outcomes in surgical, medical, and monitored patients with primary hyperparathyroidism

ea0110p242 | Bone and Mineral Metabolism

Exploring parathyroid carcinoma: clinical and pathological observations from a two-decade review

ea0110p243 | Bone and Mineral Metabolism

Obesity and blunted FGF23 response associate with kidney impairment in patients with hypoparathyroidism

ea0110p244 | Bone and Mineral Metabolism

Effects of different dietary patterns on bone health: mouse models

ea0110p245 | Bone and Mineral Metabolism

Efficacy of anastrozole in adolescent boys with limited growth potential: a retrospective analysis

ea0110p246 | Bone and Mineral Metabolism

Atypical parathyroid tumor in patients with primary hyperparathyroidism: predictive preoperative characteristics

ea0110p247 | Bone and Mineral Metabolism

Does an aggressive onset affect prognosis? insights into atypical parathyroid tumors

ea0110p248 | Bone and Mineral Metabolism

Tumour induced osteomalacia in a teenager: successful tumour localisation (68-Ga DOTATE PET-CT), tumour genetics (FGFR1 fusion gene) and tumour removal

ea0110p249 | Bone and Mineral Metabolism

Pathways to facilitate early recognition and diagnosis of hypochondroplasia

ea0110p250 | Bone and Mineral Metabolism

The IMPACT survey: healthcare experiences reported by individuals with osteogenesis imperfecta and their caregivers

ea0110p251 | Bone and Mineral Metabolism

A case of heterozygous PTHLH deletion causing brachydactyly type E2

ea0110p252 | Bone and Mineral Metabolism

Insufficient bone mineralization to sustain mechanical load of weight in obese girls: a cross-sectional study

ea0110p253 | Bone and Mineral Metabolism

Clinical significance of chloride-to-phosphorus and chloride-to-magnesium ratios in primary hyperparathyroidism

ea0110p254 | Bone and Mineral Metabolism

Phenotypic heterogeneity and long-term bisphosphonate outcomes in osteogenesis imperfecta type V: an 8-year retrospective study of 143 chinese patients

ea0110p255 | Bone and Mineral Metabolism

Solving pancreatic insufficiency as a clue to normal vitamin D serum concentrations in cystic fibrosis

ea0110p256 | Bone and Mineral Metabolism

Predictors of long-term morbidity and mortality in patients with chronic post-surgical hypoparathyroidism

ea0110p257 | Bone and Mineral Metabolism

Effective management of rebound hypercalcemia during denosumab therapy in pediatric osteogenesis imperfecta through individualized calcium supplementation

ea0110p258 | Bone and Mineral Metabolism

The significance of gender regarding the effects of primary hyperparathyroidism on the cardiometabolic profile of the patients: a single-center experience

ea0110p259 | Bone and Mineral Metabolism

Histological and laboratory factors associated with negative 99mtc-sestamibi scintigraphy in primary hyperparathyroidism: insights from a retrospective analysis

ea0110p260 | Bone and Mineral Metabolism

The complex link between obesity and bone mineral density: exploring the role of body composition

ea0110p261 | Bone and Mineral Metabolism

The diagnostic incidence of normocalcaemic hyperparathyroidism decreases and diagnostic concordance of parathyroid hormone (PTH) assays improves with assay- and age-specific PTH reference intervals

ea0110p262 | Bone and Mineral Metabolism

Profile of patients initiating abaloparatide treatment

ea0110p263 | Bone and Mineral Metabolism

Birth outcomes and educational level among patients with post-surgical and non-surgical hypoparathyroidism

ea0110p264 | Bone and Mineral Metabolism

Bone phenotype in infantile hypercalcemia-1 caused by CYP24a1 pathogenic variant

ea0110p265 | Bone and Mineral Metabolism

Pseudohypoparathyroidism type 1b diagnosed in adulthood: a novel family deletion in the GNAS locus

ea0110p266 | Bone and Mineral Metabolism

The united kingdom adult northstar network consensus recommendation of management of osteoporosis in adults with duchenne muscular dystrophy and transition to adult care

ea0110p267 | Bone and Mineral Metabolism

Vitamin d-dependent rickets type 2a in a 1-year-old girl: a rare case of alopecia and hypocalcemic jerking episodes

ea0110p268 | Bone and Mineral Metabolism

Design of the ACCEL study: a prospective clinical assessment study in children with hypochondroplasia

ea0110p269 | Bone and Mineral Metabolism

The impact of parathyroid adenoma removal on the quality of life of patients with primary hyperparathyroidism

ea0110p270 | Bone and Mineral Metabolism

Denosumab treatment of two children with inoperable spinal aneurysmal bone cysts

ea0110p271 | Bone and Mineral Metabolism

Bone mineralization in children aged 7-10 years born after assisted reproductive technology with frozen and fresh embryo transfer

ea0110p272 | Bone and Mineral Metabolism

Machine learning model on opportunistic computed tomography for predicting vertebral fracture risk in women undergoing hormone deprivation therapy for breast cancer

ea0110p273 | Bone and Mineral Metabolism

Nonsurgical hypoparathyroidism: insights from a single-center experience

ea0110p274 | Bone and Mineral Metabolism

Association of size at birth and bone mineral density in adolescents

ea0110p275 | Bone and Mineral Metabolism

Hypertension in primary hyperparathyroidism: predictive factors and post-parathyroidectomy outcomes

ea0110p276 | Bone and Mineral Metabolism

Years later: cracking the mystery of x-linked hypophosphatemic rickets

ea0110p277 | Bone and Mineral Metabolism

Pediatric parathyroid adenomas: a single tertiary care center experience

ea0110p278 | Bone and Mineral Metabolism

Patient-reported outcomes and quality of life in children and adults with hpp treated with asfotase alfa

ea0110p279 | Bone and Mineral Metabolism

Hospitalizations in people with rare bone diseases across age groups: a population-based cohort study in switzerland

ea0110p280 | Bone and Mineral Metabolism

Clinical features of pediatric hypophosphatasia and eight-year outcomes of enzyme replacement therapy in korea

ea0110p281 | Bone and Mineral Metabolism

Persistent hypercalcaemia in trisomy 21: consider ABCD syndrome

ea0110p282 | Bone and Mineral Metabolism

Genotype-phenotype correlations and therapeutic outcomes in osteogenesis imperfecta type vi: an 11. 5-year cohort study of 36 chinese pediatric patients

ea0110p283 | Bone and Mineral Metabolism

Onset of puberty in achondroplasia

ea0110p284 | Bone and Mineral Metabolism

Diabetes mellitus marginally impairs bone quality with chronic kidney disease

ea0110p285 | Bone and Mineral Metabolism

Biochemical response kinetics in vitamin d resistant rickets (VDDR) type 1 and 2: 13-year retrospective analysis from a tertiary care centre

ea0110p286 | Bone and Mineral Metabolism

Severe short stature secondary to distal renal tubular acidosis with slc4a1 gene mutation in a nigerian adolescent

ea0110p287 | Bone and Mineral Metabolism

Localization imaging and postoperative outcomes in primary hiperparathyroidism (phpt): is less enough?

ea0110p288 | Bone and Mineral Metabolism

Management of osteoporosis in a pediatric case of severe osteolysis

ea0110p289 | Bone and Mineral Metabolism

Hereditary and acquired phosphopenic rickets: from childhood to adulthood

ea0110p290 | Bone and Mineral Metabolism

Parathyroid washout’s role in accurate adenoma localisation and diagnostic cut-offs

ea0110p291 | Bone and Mineral Metabolism

Pubertal development in hypophosphatemic rickets: does it have an impact on growth?

ea0110p292 | Bone and Mineral Metabolism

Pregnancy management in ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (ENPP1) deficiency: a case report and considerations for maternal medicine care

ea0110p293 | Bone and Mineral Metabolism

"Familial hypocalciuric hypercalcemia in adolescence: diagnostic challenges and the role of genetic testing"

ea0110p294 | Bone and Mineral Metabolism

"A diagnostic odyssey: camurati - engelmann syndrome presenting as childhood onset leg pains and stiffness"

ea0110p295 | Bone and Mineral Metabolism

Bone health index (BHI) in children with osteogenesis imperfecta: is it an accurate tool for predicting fracture risk?

ea0110p296 | Bone and Mineral Metabolism

Clinical and laboratory characteristics of genetic rickets: a single-center experience with long-term outcomes

ea0110p297 | Bone and Mineral Metabolism

A novel case of macroprolactinoma in a patient with phenylketonuria

ea0110p298 | Bone and Mineral Metabolism

Trabecular bone score and risk of vertebral fracture in systemic lupus erythematosus children and adolescent who treated with glucocorticoids

ea0110p299 | Bone and Mineral Metabolism

Hypercalcaemia from primary hyperparathyroidism and CYP24a1 pathogenic variant: a coincidence or an underlying mechanism?

ea0110p300 | Bone and Mineral Metabolism

Effect of long-term treatment with teriparatide and vitamin k on bone density and bone markers, glucose metabolism and body composition in severe osteoporotic patients

ea0110p301 | Bone and Mineral Metabolism

Prevention and treatment of hypocalcaemia in children undergoing total thyroidectomy

ea0110p302 | Bone and Mineral Metabolism

X-linked hypophosphatemic rickets in children and adolescents - single centre expertise in romania

ea0110p303 | Bone and Mineral Metabolism

From highs to lows: the challenge of hypocalcemia after parathyroid carcinoma surgery

ea0110p304 | Bone and Mineral Metabolism

Biochemical ratios for predicting primary hyperparathyroidism: revisiting simple yet powerful diagnostic tools

ea0110p305 | Bone and Mineral Metabolism

Bone marrow stem cells derived exosomes for osteoporosis treatment

ea0110p306 | Bone and Mineral Metabolism

Jaw tumor syndrome: a rare endocrine disorder with diverse clinical manifestations

ea0110p307 | Bone and Mineral Metabolism

Heterozygous WNT1 variant causing severe, adult-onset hereditary osteoporosis

ea0110p308 | Bone and Mineral Metabolism

Infantile idiopathic hypercalcemia associated with heterozygous mutation of SLC34A1: a case series

ea0110p309 | Bone and Mineral Metabolism

Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025: Connecting Endocrinology Across the Life Course

BiosciAbstracts